Postspinal Headache and Near Infrared Spectroscopy (NIRS)

NCT ID: NCT04187846

Last Updated: 2019-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-15

Study Completion Date

2020-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the relationship between postspinal headache and near infrared spectroscopy in cesarean section patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with cesarean section under spinal anesthesia were included in the study. Before the study, patients were moniterized with NIRS device in the preoperative waiting room.NIRS moniterization was continued intraoperatively at 1st, 4th, 7th, 10th, 15th, 30th minutes and 24th postoperative period.

Patients were divided into two groups as those with postspinal headache (Group A) and those with postspinal headache (Group B). In this study, NIRS values between two groups were compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tissue Oxygenation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective cesarean section

Exclusion Criteria

* Not willing to participate in the study
* Use of anti-psychotic or anti-depressant drugs
* Patients with headaches
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hakan Tapar

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hakan Tapar

Assistant professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hakan Tapar

Role: PRINCIPAL_INVESTIGATOR

Gaziosmanpasa University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gaziosmanpasa University

Tokat Province, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hakan Tapar

Role: CONTACT

+905056844496

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hakan Tapar, Assist.Prof.

Role: primary

+905056844496

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-KAEK-167

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Determination of Blood Loss After CS
NCT04549012 UNKNOWN EARLY_PHASE1